-
1 Comment
Zhejiang Huahai Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 25.8% below its 200 day moving average.
From a valuation standpoint, the stock is 39.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.8.
Zhejiang Huahai Pharmaceutical Co., Ltd's total revenue rose by 15.2% to $2B since the same quarter in the previous year.
Its net income has increased by 48.1% to $262M since the same quarter in the previous year.
Finally, its free cash flow fell by 70.2% to $133M since the same quarter in the previous year.
Based on the above factors, Zhejiang Huahai Pharmaceutical Co., Ltd gets an overall score of 3/5.
| Exchange | SHG |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE000001DL5 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | 23B |
|---|---|
| PE Ratio | 19.31 |
| Target Price | 19.93 |
| Beta | 0.5 |
| Dividend Yield | None |
Zhejiang Huahai Pharmaceutical Co., Ltd. operates as a pharmaceutical company in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates. It also provides packaging components, such as high-density polyethylene bottles and polypropylene caps for pharmaceuticals. In addition, the company offers contract manufacturing and other services, as well as import and export trade services. The company was founded in 1989 and is headquartered in Linhai, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 600521.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
